Zobrazeno 1 - 10
of 100
pro vyhledávání: '"R. Flener"'
Autor:
S. Charles Schulz, Christy R. Flener, Sean Kowaliw, Beverly Donovan, Mary Ann Semple, Peter F. Goyer, Colleen Lewis, William E. Semple, Kevan Mccutcheon, Raymond F. Muzic, David Liebling, Richard A. McCormick, Loreen Rugle, Ken Vapenik
Publikováno v:
Psychiatry. 63:65-74
Posttraumatic stress disorder (PTSD) patients with histories of cocaine and alcohol abuse (CA-PTSD) were compared with normal volunteers. Positron emission tomography (PET) scans with 15O-butanol were used to compare regional cerebral blood flow (rCB
Autor:
Walter E. Aulitzky, Gerd Judmaier, R. Flener, Günther Gastl, Manfred Herold, Robert Mull, Wolfgang Vogel, Christoph Huber, Herbert Tilg, Manuela Berger
Publikováno v:
European journal of cancer (Oxford, England : 1990). 27(4)
The pharmacokinetics, toxicity and biological effects of subcutaneous and intramuscular treatment of cancer patients with recombinant tumour necrosis factor alpha (rTNF-alpha) was investigated. 17 patients suffering from refractory malignant disease
Publikováno v:
Oncology. 42:26-32
There is as yet no effective treatment for renal cell carcinoma and metastasizing malignant melanoma. This fact, coupled with in vitro investigations showing growth inhibitory or cytotoxic effects of interferon (IFN) on renal cell carcinoma and melan
Autor:
Jakob Troppmair, Erich Pohanka, Josef Kovarik, E. Leiter, Ch. Huber, Schwarz M, Raimund Margreiter, W. Woloszczuk, R. Flener
Publikováno v:
Transplantation. 41:716-718
We have recently shown that interferon-gamma is capable of activating the key enzyme of pterin biosynthesis in macrophages. This leads to excretion of the stable degradation product neopterin. In this article we present experimental evidence suggesti
Publikováno v:
Oncology. 42:7-9
The efficacy of recombinant interferon-α2 in the treatment of advanced hairy cell leukaemia is investigated in 31 patients. Preliminary results show a complete and partial response rate of
Autor:
A. Clarós, R. Monsieur, J.Th.P. Janssen, Z. Labas, R. van Tol, P. Clarós, B Van Camp, Elke Fritz, R. Kuzmits, Pierre Stryckmans, Jorge R. Quesada, O. Ribari, R. Pavelka, L.P. Löbe, D. Niethammer, Razelle Kurzrock, Elio Polli, Heinz Ludwig, Guenther Gastl, G.R. Adolf, Jordan U. Gutterman, A. Keyser, Helmut Sinzinger, Thierry Velu, Moshe Talpaz, Ch. Huber, H. Hirche, E. M. Kokoschka, Agostino Cortelezzi, Michael Micksche, Michael G. Rosenblum, R. Bellens, R. Flener, J. Wybran, Werner Scheithauer, W. Kley, Adan Rios, H.P. Zenner, P. Plath, Heinz Gisslinger, B.E. de Pauw, J. Flament, Stephen A. Sherwin, D. Gangji, Werner Linkesch, Francis Delwiche
Publikováno v:
Oncology. 42:I-III
Autor:
C. Huber, R. Flener, G. Gastl, J. Wiegele, W. Vogel, W. E. Aulitzky, B Mull, E. Böheim, Marco J Herold, H. Tilg, H. Denz, W. Aulitzky, G. Judmaier, M. Berger, E. Pichler
Publikováno v:
Journal of interferon research. 8(5)
The effect of different doses of recombinant human tumor necrosis factor-alpha (rTNF-alpha) on serum levels of neopterin, beta-2-microglobulin and interferon-gamma (IFN-gamma) was investigated in tumor patients. Twelve patients with advanced malignan
Autor:
W, Aulitzky, G, Gastl, J, Troppmair, H, Tilg, K, Abbrederis, C, Nerl, R, Flener, H, Rokos, C, Huber
Publikováno v:
Acta medica Austriaca. 12(5)
Hairy-cell leukemia has been shown to be extraordinary sensitive to treatment with alpha-interferon. In order to define clinically effective interferon doses associated with minimal toxicity two different dose regimens were applied in this clinical t
Autor:
J, Troppmair, K, Nachbaur, M, Herold, W, Aulitzky, H, Tilg, G, Gastl, P, Bieling, B, Kotlan, R, Flener, B, Mull
Publikováno v:
Clinical and experimental immunology. 74(3)
Recently we presented evidence that cellular immune responses are associated with increased in-vitro and in-vivo excretion of neopterin (Huber et al., 1983) and that, in vitro at least, macrophages and IFN-gamma play a key role in the induction of th